Like many metal-on-metal hip replacements, some Biomet M2a Magnum and M2a Acetabular 38mm recipients are finding that their implants are causing them pain, dislocation, and metal poisoning. Read more.
As of now, no. However, there’s always a possibility that there will be a recall in the future. Read more.
Yes. In fact hundreds have joined the federal multidistrict litigation (MDL) pending in the U.S. District Court for the Northern District of Indiana. Read more.
MDL is a process similar to a class action that centralizes all lawsuits related to a specific product before one judge for pretrial proceedings. Read more.
As of January 15, 2014, there were approximately 950 lawsuits pending in the Biomet MDL. This means that all of those cases were consolidated into a single federal court in in Illinois for efficiency in certain pretrial processes, such as document discovery. However, unlike a class action, an MDL allows for each plaintiff’s lawsuit to go to trial and for each plaintiff to receive his or her own damages award. There are no shared awards like you would find in a class action.
On January 31, 2014, Biomet and the plaintiffs in the MDL agreed to a mass settlement totaling $50 million with base awards beginning at $200,000 per revised hip. Read more.